Avisa Diagnostics Inc FOGCF

Avisa Diagnostics Inc. is a clinical-stage medical device company. The Company is engaged in the development of the Allora BreathTest (ABT), a drug/device biomarker technology platform. The Allora BreathTest (ABT) is an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of bacterial load. ABT enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its drug substrates via its own delivery systems. Its ABT portfolio includes Post-Covid-19 Bronchiectasis, Develo, Ventilator-Associated Pneumonia (VAP), Chronic Obstructive Pulmonary Disease (COPD), Community-Acquired, Pneumonia (CAP), Cystic Fibrosis, Tuberculosis, Aspergillus Fungus and Clostridium Difficile (C. diff).

GREY:FOGCF - Post by User

Avisa Diagnostics Inc > you think we will open before the consolodation is done? or

<< Previous

Bullboard Posts

Next >>

Comment by sawrieon Feb 03, 2021 12:25pm

83 Views

Post# 32459096

RE:you think we will open before the consolodation is done? or

we should open before the takeover, but if we don't it is hard to say what will happen: all depends on the news that accompanies the reverse takeover. There will probably be a lot of interest in buyers wanting in on a public avista and once institutional buyers become aware of it, the sky is the limit.

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions